{
    "organizations": [],
    "uuid": "119313dcc9f0dadb768ffb93834a2b6a4bc8fdb8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ziopharm-oncology-to-initiate-pivo/brief-ziopharm-oncology-to-initiate-pivotal-trial-of-cancer-treatment-in-second-half-of-2018-idUSASB0C0BJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Ziopharm Oncology To Initiate Pivotal Trial Of Cancer Treatment in Second Half of 2018",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 50 PM / Updated 8 minutes ago BRIEF-Ziopharm Oncology To Initiate Pivotal Trial Of Cancer Treatment in Second Half of 2018 Reuters Staff \nJan 9 (Reuters) - Ziopharm Oncology Inc: \n* ZIOPHARM ONCOLOGY PROVIDES UPDATE ON STANDOUT TECHNOLOGIES DURING THE 36TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE \n* ZIOPHARM ONCOLOGY - UPDATED GUIDANCE ON PLANNED PIVOTAL TRIAL TO EVALUATE CONTROLLED IL-12 AND ANNOUNCED THAT IT WILL INITIATE IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:",
    "published": "2018-01-09T20:50:00.000+02:00",
    "crawled": "2018-01-09T15:01:56.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "oncology",
        "initiate",
        "pivotal",
        "trial",
        "cancer",
        "treatment",
        "second",
        "half",
        "reuters",
        "staff",
        "jan",
        "reuters",
        "ziopharm",
        "oncology",
        "inc",
        "ziopharm",
        "oncology",
        "provides",
        "update",
        "standout",
        "technology",
        "36th",
        "annual",
        "morgan",
        "healthcare",
        "conference",
        "ziopharm",
        "oncology",
        "updated",
        "guidance",
        "planned",
        "pivotal",
        "trial",
        "evaluate",
        "controlled",
        "announced",
        "initiate",
        "second",
        "half",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}